These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 6089991
21. Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma. Lin CP, Yu HC, Cheng JS, Lai KH, Lo GH, Hsu PI, Lin CK, Chen HH, Lo CC, Liang HL, Tseng HH. J Chin Med Assoc; 2004 Dec; 67(12):602-10. PubMed ID: 15779483 [Abstract] [Full Text] [Related]
22. Superselective intra-arterial chemotherapy with mitomycin C in liver and gallbladder cancer. Kairaluoma MI, Leinonen A, Niemelä R, Kiviniemi H, Siniluoto T, Ståhlberg M. Eur J Surg Oncol; 1988 Feb; 14(1):45-50. PubMed ID: 3126085 [Abstract] [Full Text] [Related]
23. Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer. Liu LX, Zhang WH, Jiang HC, Zhu AL, Wu LF, Qi SY, Piao DX. World J Gastroenterol; 2002 Aug; 8(4):663-7. PubMed ID: 12174375 [Abstract] [Full Text] [Related]
24. Mitomycin C in advanced gallbladder carcinoma. von Eyben F, Hellekant C, Mattsson W, Ljungquist U, Jonsson K. Acta Radiol Oncol; 1980 Aug; 19(2):81-4. PubMed ID: 6254338 [Abstract] [Full Text] [Related]
25. Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin. Seki H, Ohi H, Ozaki T, Yabusaki H. Acta Radiol; 2016 Jul; 57(7):781-8. PubMed ID: 26339040 [Abstract] [Full Text] [Related]
26. [A 5-FU, ADR, MMC combined hepatic arterial infusion therapy in non-resectable liver metastases from colon and gastric cancer]. Arai Y, Endo T, Miyake Y, Sakamoto K, Kido C. Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2731-4. PubMed ID: 2782885 [Abstract] [Full Text] [Related]
33. [Continuous hepatic arterial infusion chemotherapy with low-dose CDDP plus 5-FU for liver metastases from colorectal carcinoma]. Kohnoe S, Taketomi A, Morita M, Baba H, Matsuoka H, Seo Y, Saito T, Tomoda H. Gan To Kagaku Ryoho; 1996 Sep; 23(11):1429-32. PubMed ID: 8854771 [Abstract] [Full Text] [Related]
34. [Three cases of effective hepatic arterial infusion with OK-432, mitomycin C and 5-fluorouracil in liver metastasis from gastric cancer]. Mori N, Hamada H, Nakamura T, Tanaka A, Nakajima I, Nakamura Y, Wada T, Yasutomi M. Gan To Kagaku Ryoho; 1989 Oct; 16(10):3473-6. PubMed ID: 2508570 [Abstract] [Full Text] [Related]
35. [5-FU/ADR/MMC combined hepatic infusion in liver metastases from gastric cancer]. Arai Y, Kido C, Endo T, Miyake Y, Sato Y, Ozawa H. Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2433-6. PubMed ID: 3415254 [Abstract] [Full Text] [Related]
40. [Preliminary results of a phase II study of 5-FU, adriamycin, and mitomycin C (FAM) in combined hepatic infusion in patients with non-resectable metastatic liver cancer]. Arai Y, Kido C, Endo T, Aoki T. Gan To Kagaku Ryoho; 1987 Jul; 14(7):2327-33. PubMed ID: 3606152 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]